Technical Analysis for CORI - Corium International, Inc.

Grade Last Price % Change Price Change
grade A 12.44 -1.03% -0.13
CORI closed down 1.03 percent on Friday, February 16, 2018, on 40 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
0 Watchers
Track This Stock
Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical CORI trend table...

Date Alert Name Type % Chg
Feb 16 Narrow Range Bar Range Contraction 0.00%
Feb 16 NR7 Range Contraction 0.00%
Feb 16 Inside Day Range Contraction 0.00%
Feb 16 Wide Bands Range Expansion 0.00%
Feb 15 Outside Day Range Expansion -1.03%
Feb 15 Wide Bands Range Expansion -1.03%
Feb 14 Wide Bands Range Expansion -1.03%
Feb 13 Wide Bands Range Expansion -0.32%
Feb 12 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 3.41%
Feb 12 Inside Day Range Contraction 3.41%

Older signals for CORI ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Corium International, Inc., a biopharmaceutical company, focuses on the research, development, manufacture, and commercialization of specialty pharmaceutical products. Its products include Clonidine Transdermal Delivery System (TDS), a treatment for hypertension; Fentanyl TDS, a treatment for management of chronic pain, including cancer-related pain; Crest Whitestrips, a series of four products under the Advanced Vivid, Professional Effects, One Hour Express, and Flex-Fit brands for oral care. The company is also developing AG200-15, a combination hormonal contraceptive patch in Phase III clinical trials that delivers ethinyl estradiol and levonorgestrel hormones; MicroCor hPTH(1-34), a transdermal system, which has completed Phase I clinical trials for the treatment of severe osteoporosis; and Corplex Tamsulosin that has completed Phase I clinical trials for the treatment of benign prostatic hyperplasia. In addition, its products that have completed development, scale-up, and clinical activities include motion sickness patch for the prevention of nausea and vomiting associated with motion sickness; and urology patch for treatment of a urologic condition. Further, the company is developing Donepezil and Memantine transdermal patches for the treatment of Alzheimer's disease; and Ropinerole and Pramipexole therapies for the treatment of Parkinson's disease. Corium International, Inc. has collaboration agreements with The Procter & Gamble Company, Teva Pharmaceuticals USA, Inc., Par Pharmaceutical, Inc., and Agile Therapeutics, Inc. The company was incorporated in 1995 and is headquartered in Menlo Park, California.
Is CORI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 13.93
52 Week Low 3.44
Average Volume 198,139
200-Day Moving Average 9.5075
50-Day Moving Average 11.6435
20-Day Moving Average 12.7065
10-Day Moving Average 12.274
Average True Range 0.6654
ADX 20.4
+DI 14.91
-DI 18.88
Chandelier Exit (Long, 3 ATRs ) 11.9338
Chandelier Exit (Short, 3 ATRs ) 13.3712
Upper Bollinger Band 13.7836
Lower Bollinger Band 11.6294
Percent B (%b) 0.38
BandWidth 16.953528
MACD Line 0.1638
MACD Signal Line 0.2444
MACD Histogram -0.0805
Fundamentals Value
Market Cap 444.63 Million
Num Shares 35.7 Million
EPS -1.72
Price-to-Earnings (P/E) Ratio -7.23
Price-to-Sales 10.96
Price-to-Book 12.08
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.86
Resistance 3 (R3) 12.88 12.77 12.79
Resistance 2 (R2) 12.77 12.66 12.76 12.77
Resistance 1 (R1) 12.60 12.59 12.55 12.58 12.74
Pivot Point 12.49 12.49 12.46 12.48 12.49
Support 1 (S1) 12.32 12.38 12.27 12.30 12.14
Support 2 (S2) 12.21 12.31 12.20 12.11
Support 3 (S3) 12.04 12.21 12.09
Support 4 (S4) 12.02